SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weaker-than-expected outlook after its quarterly reportciting softness in the PC market and manufacturing constraintshas driven a sharp selloff despite stronger data-center demand. Traders are split between viewing the drop as an overreaction and expecting further declines as near-term growth and execution concerns weigh on sentiment.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is drawing attention after reports of a major Binance security breach coincided with a sharp crypto selloff, prompting concerns about exchange security and confidence across the sector. Traders are split between warning of further downside and treating the pullback as a buying opportunity, with some arguing the incident affected an exchange rather than Bitcoin itself.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks strong quarterly results and raised outlook were followed by a sharp selloff, prompting widespread frustration that the stock fell despite the beat. Traders debate whether broader tech weakness and profit-taking explain the move, while some cite concerns about memory pricing and Kioxias outlook; others argue demand and fundamentals remain strong.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results and outlook have weighed on the stock, as investors focus on heavy AI infrastructure spending and negative free cash flow despite accelerating AWS growth. Traders are divided between concern that spending may outrun returns and views that the selloff is an overreaction to investment in a fast-growing cloud business.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoin weakness tied to reports of a major Binance security incident is weighing on MSTR alongside mixed Q3 results: revenue missed, while reported profit was largely driven by gains on Bitcoin holdings, and the company disclosed a CFO transition. Traders are split between viewing the selloff as a crypto-driven buying opportunity and citing dilution, dividend obligations, and leadership uncertainty as reasons for caution.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples unusual resilience while other mega-cap and AI stocks sell off is widely attributed by traders to a rotation into the stock as a safe haven and an anti-AI-capex hedge. The strength is drawing skepticism over its high valuation and whether it can hold up through earnings, while bulls view its cash generation and lower AI spending as defensive advantages.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddits selloff follows weaker-than-expected fourth-quarter revenue guidance, a miss on user growth, and managements warning that Google search referrals are declining; plans to test logged-in-only access have added concern that traffic could fall further. Traders are debating whether the reaction is excessive given strong revenue growth, while many focus on the risks to users and future growth.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Weak technology earnings and doubts about returns on heavy AI spendingparticularly after Amazon and Intel resultsare fueling concern about a broader tech-led pullback. Traders are split between calling it an AI-trade unwind and treating the decline as a buyable dip, with some noting SPY has held up better than tech-heavy QQQ.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians quarterly results beat expectations as R2 deliveries ramped, and the company raised its full-year delivery outlook, prompting optimism about improving execution and growth. Traders remain divided over whether the stronger outlook can offset ongoing losses and cash burn, while some also caution that the post-earnings move may fade; speculation about a Walmart van deal remains unconfirmed.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Weak Amazon and Intel results have intensified selling across technology and chip stocks, with traders focused on whether heavy AI infrastructure spending will generate adequate returns. The community is debating whether the pullback signals an AI-trade bubble bursting or a buying opportunity, while some also cite rising oil and geopolitical uncertainty as added pressure.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETFs That You May Consider Amid a Strengthening Biotech Outlook

Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.

BNTX Stock Selloff Deepens Doubts: BMO Ties BNT113 Miss To Wider mRNA Cancer Vaccine Struggles

Equity

BMO Capital Markets analyst Evan David Seigerman said that the PFS miss for BNT113 “adds to a growing list of recent mRNA cancer vaccine setbacks” and is likely to pressure the stock. 


Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate 

Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP

Biotech ETFs are riding innovation, obesity drug growth and M&A, offering diversified exposure to the sector???s powerful rally.

Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth 

 Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.

ONC Stock Gains As BeOne Medicines Wins US Nod For BEQALZI In Rare Lymphoma

The FDA approved BEQALZI in the treatment of certain mantle cell lymphoma patients on Wednesday. 


First Trust Exchange-Traded Fund - First Trust NYSE Arca Biotechnology Index Fund

Neutral Sentiment

<ul class="summary-bullets"><li>Seigerman highlighted two recent discontinuations for the individualized mRNA candidate autogene cevumeran — jointly developed by BioNTech and Genentech — in bladder cancer and colorectal cancer.</li><li>Evercore ISI called the PFS miss “disappointing, but consistent with our reading of the earlier Phase 2 data.”</li><li>Citi pointed out that the trial design still allows a positive outcome if OS improves, “preserving a meaningful development path.”</li></ul> BioNTech shares (BNTX) closed down roughly 7% on Tuesday after the company reported that its investigational mRNA cancer immunotherapy BNT113 failed to show a statistically significant progression-free survival (PFS) benefit in a key late-stage trial, a result an analyst said reflects a broader pattern of challenges for mRNA cancer vaccines.In the Phase 2/3 AHEAD-MERIT study, BNT113—an off-the-shelf mRNA immunotherapy —was tested in combination with Merck’s drug pembrolizumab versus pembrolizumab alone as first-line treatment for certain patients with unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma.At the first analysis of the dual primary endpoints, the combination did not show a statistically significant PFS improvement, the company said on Tuesday. The independent data monitoring committee recommended that the trial continue as planned to assess overall survival, the second primary endpoint. Under the pre-specified trial design, a significant OS benefit would still constitute a positive outcome even without a PFS win.<h2 class="st-heading-2">BNTX Analyst Reactions Highlight Reduced Confidence</h2>BMO Capital Markets analyst Evan David Seigerman said that the PFS miss “adds to a growing list of recent mRNA cancer vaccine setbacks” and is likely to pressure the stock.Seigerman, who maintains a Market Perform rating and $105 price target, said the miss on progression-free survival (PFS)—the length of time patients lived without their cancer getting worse—for BNT113 plus pembrolizumab in the AHEAD-MERIT study leaves open the possibility of a later overall survival (OS) benefit, meaning patients living longer overall, but with significantly reduced confidence.He highlighted two recent discontinuations for the individualized mRNA candidate autogene cevumeran — jointly developed by BioNTech and Genentech — in bladder cancer and colorectal cancer. While an OS improvement is still possible, BMO views it as less likely given today’s miss.Evercore ISI and Citi called the PFS miss disappointing. Evercore, which rates the shares ‘Outperform’ with a $130 target, said BioNTech’s valuation is tied more closely to the outlook for its pumitamig program and rival Summit Therapeutics’ upcoming readout for its experimental drug ivonescimab in first-line metastatic non-small-cell lung cancer than to this single result.Citi kept a ‘Buy’ rating and $125 target, and pointed out that the trial design still allows a positive outcome if OS improves, “preserving a meaningful development path.”<h2 class="st-heading-2">BioNTech's Optimistic Stance</h2>BioNTech Chief Medical Officer Özlem Türeci stated on Tuesday that while the PFS result was not statistically significant, the data support continued evaluation and indicate the candidate is engaging its intended mechanism. She emphasized that immune-mediated anti-tumor effects can build over time, making the OS analysis critical for assessing durable benefit in this HPV-driven disease, for which no approved HPV-targeted therapies currently exist.Investors will now watch for OS data from AHEAD-MERIT, expected later, as the company continues to position mRNA immunotherapies as a core pillar of its oncology strategy amid the transition away from COVID-19 vaccine revenues.<h2 class="st-heading-2">How Did BNTX Retail Traders React?</h2>On Stocktwits, retail sentiment around <a class="mention" data-mention="$BNTX" data-symbol-id="BNTX" href="https://stocktwits.com/symbol/BNTX" target="_blank">BNTX stock</a> jumped from neutral to bullish territory over the past 24 hours, while message volume stayed at normal levels.A Stocktwits user opined that the stock will slip further, noting that the company’s CEO Uğur Şahin, as well as CMO Özlem Türeci, who also co-founded the company, are slated to step down by the end of the year, leaving the company without fresh leadership for a while.<stembedurl>https://stocktwits.com/IndyOne/message/666392163</stembedurl>Another user opined that the trial outcome was expected given the difficulty of treating late-stage cancer and voiced optimism for the company’s other oncology assets.<stembedurl>https://stocktwits.com/eightytwentie/message/666385168</stembedurl>BNTX stock has fallen by about 7% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/gme-rises-after-hours-as-ryan-cohen-buys-another-844-k-shares-worth-near-23-m/cZxBuMNRBYp">GME Rises After Hours As Ryan Cohen Buys Another 844K Shares Worth Near $23M</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Keenjee Nama, senior research nurse, holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell lung cancer (NSCLC) at the University College London Hospital clinical research facility, Picture date: August 20, 2024. (Photo by Aaron Chown/PA Images via Getty Images)

BMO Capital Markets analyst Evan David Seigerman said that the PFS miss for BNT113 “adds to a growing list of recent mRNA cancer vaccine setbacks” and is likely to pressure the stock. 

BioNTech SE - ADR

First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund

iShares Biotechnology ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

FBT First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund

Fundamentals

Latest FBT News